Cardiac Meds Appear to Protect Heart From Herceptin Damage

Admin • CCON • 12/15/2015

SAN ANTONIO ― Breast cancer patients treated with trastuzumab (Herceptin, Genentech, Inc) had significantly lower risk for left ventricular (LV) dysfunction and consequent treatment interruptions when treated prophylactically with heart failure medications, researchers reported at San Antonio Breast Cancer Symposium (SABCS) 2015.

Read More

By Kate Johnson – Medscape Medical News, Conference News

December 15, 2015